Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing brain health and dementia research in Canada: insights from focus groups with the Dementia Research and Innovation Funders Alliance.

The Gerontologist·2026
Same author

Association between anticholinergic and sedative medications and physical functioning: data from the Canadian longitudinal study on aging (CLSA).

European journal of clinical pharmacology·2026
Same author

Implementation and Evaluation of Virtual Care in Canadian Health Care Systems: A Scoping Review.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association·2026
Same author

Mapping the Landscape, Knowledge Gaps, and Areas for Innovation in Brain Health and Dementia Research in Canada: Protocol for a Scoping Review of Reviews.

JMIR research protocols·2026
Same author

Mapping the Landscape, Knowledge Gaps, and Areas for Innovation in Brain Health and Dementia Research in Canada: A Scoping Review of Reviews Protocol.

JMIR research protocols·2026
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Anxiety in multiple sclerosis: an exploratory cross-sectional study of psychological, social, clinical, and neuroimaging factors.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2026
Same journal

Correction to: Can Research Findings be Used in Clinical Neuropsychology? Analysis of Randomized Controlled Trials of Working Memory Intervention for Children.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2026
Same journal

Safety-critical odor identification failure and cognitive performance in older U.S. adults: a cross-sectional NHANES analysis.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2026
Same journal

Does performance invalidity undermine replication? Evidence from an undergraduate student participant sample.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2026
Same journal

The relationship between subjective cognitive complaints and objective cognitive assessment in severe mental disorders: a systematic review and meta-analysis.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2026
Same journal

Cognitive rehabilitation in contemporary neuropsychological practice: an exploratory survey of service delivery, reimbursement, and perceived barriers.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Age corrections and dementia classification accuracy.

Megan E O'Connell1, Holly Tuokko

  • 1Department of Psychology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. megan.oconnell@usask.ca

Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
|February 2, 2010
PubMed
Summary
This summary is machine-generated.

Demographic corrections, like those for age, do not always improve diagnostic accuracy and can sometimes decrease it. While corrected scores may offer better specificity, raw scores often show higher sensitivity in dementia assessments.

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Related Experiment Videos

Last Updated: Jun 16, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Area of Science:

  • Neuropsychology
  • Biostatistics
  • Gerontology

Background:

  • Diagnostic classification accuracy in neuropsychological testing can be influenced by demographic factors such as age and education.
  • Standardization of test scores using demographic corrections aims to reduce potential biases.
  • Age is a known risk factor for dementia, complicating age-based demographic corrections.

Purpose of the Study:

  • To investigate whether demographic corrections universally improve diagnostic classification accuracy.
  • To evaluate the impact of age-based demographic corrections on dementia risk simulation and classification.
  • To compare the sensitivity and specificity of raw versus demographically corrected test scores.

Main Methods:

  • Simulated dementia risk based on demographic variables, including age.
  • Analysis of classification accuracy using both raw and demographically corrected test scores.
  • Comparison of score sensitivity and specificity at specific percentiles (16th and 9th) in simulated and clinical data.

Main Results:

  • Demographic corrections did not universally enhance diagnostic classification accuracy.
  • Simulated increased dementia risk based on age reduced classification accuracy for corrected scores compared to raw scores.
  • In clinical data with weak age-dementia association, corrected and raw scores showed similar overall accuracy.
  • Raw scores generally exhibited higher sensitivity, while demographically corrected scores demonstrated superior specificity.

Conclusions:

  • Demographic corrections, particularly for age, may not always improve diagnostic accuracy and can potentially hinder it.
  • The utility of demographic corrections depends on the specific demographic variable and its association with the diagnosis.
  • While corrected scores may offer improved specificity, raw scores might be more sensitive for detecting cognitive impairment.